This Tech Megatrend Isn’t on Wall Street’s Radar
While tech stocks have been hit hard by the recent sell-off, Jeff Brown believes we’ll see this sector rally...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.
While tech stocks have been hit hard by the recent sell-off, Jeff Brown believes we’ll see this sector rally...
CRISPR is like software programming for DNA, and U.K.-based researchers just demonstrated how to use it to stop tomatoes...
With the potential for more aggressive interest-rate hikes and rising inflation, it makes sense to approach this market with...
A recent Bleeding Edge topic, DeSoc, would provide a way to document and validate our key credentials. But our...
Volatility is scaring investors away from potentially groundbreaking investments, so where should we turn next? Jeff Brown has been...
With all of the fear in the market, Jeff has been keeping a close eye on indicators that allow...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.